EUA
Mount Sinai SARS-CoV-2 Assay
FDA Emergency Use Authorization · The Mount Sinai Hospital, Center for Clinical Laboratories · Aug 23, 2021
Key facts
| Product | Mount Sinai SARS-CoV-2 Assay |
|---|---|
| Company | The Mount Sinai Hospital, Center for Clinical Laboratories |
| Product type | Real-time RT-PCR, Home Collection, Saliva, Screening, Multiple Targets |
| Date | Aug 23, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: